Product/Composition:- | Efavirenz |
---|---|
Strength:- | Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg |
Form:- | Tablet & Capsule |
Reference Brands:- | Sustiva®(US); Stocrin®(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Efavirenz Tablets, a key NNRTI for HIV treatment, are available in 200 mg and 600 mg strengths. PharmaB2B connects global buyers with certified manufacturers offering bulk supply and fixed-dose combos like Atripla. Ideal for compliant sourcing in tenders, HIV programs, and international pharmaceutical trade.
Efavirenz Tablets are widely used as part of combination therapy for HIV-1 treatment, classified under NNRTIs. Commonly available in 600 mg and pediatric strengths, Efavirenz is also found in fixed-dose combinations like Atripla®. On PharmaB2B platforms, bulk buyers and distributors can connect with GMP-certified manufacturers for high-quality Efavirenz products. Ideal for hospitals, HIV programs, NGOs, and government tenders, PharmaB2B supports cost-effective and compliant procurement across global markets. Whether sourcing single or combo formulations, buyers benefit from reliable supply chains and competitive pricing. Choose PharmaB2B for trusted suppliers of Efavirenz and other essential antiretrovirals.